The Discounted Cash Flow (DCF) valuation of AtriCure Inc (ATRC) is (20.73) USD. With the latest stock price at 32.30 USD, the upside of AtriCure Inc based on DCF is -164.2%.
Based on the latest price of 32.30 USD and our DCF valuation, AtriCure Inc (ATRC) is a sell. selling AtriCure stocks now will result in a potential gain of 164.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.5% - 10.1% | 8.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (58.08) - (12.90) | (20.73) |
| Upside | -279.8% - -139.9% | -164.2% |